Cancer Gene Therapy - Table of Contents alert Volume 22 Issue 11

If you are unable to see the message below, click here to view.

Advertisement Nature Genetics and Nature Reviews Cancer present: NUCLEAR REPROGRAMMING AND THE CANCER GENOME 2016 Sponsored by CapitalBio Corporation February 21-23, 2016 | La Jolla, CA, USA REGISTER NOW! TABLE OF CONTENTS Volume 22, Issue 11 (November 2015) In this issue Review Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement SUBMIT TO CANCER GENE THERAPY Over 105,000 eAlert registrants will receive your paper in their inbox Average of 83,000 page views across the Cancer Gene Therapy website On average, authors receive a first decision on their paper within 34 working days Impact Factor of 2.416, 64/123 in Medicine, Research & Experimental category     (2014 Journal Citation Reports®,Thomson Reuters) Find out how to submit your research today   Review Top CRISPR/Cas9: molecular tool for gene therapy to target genome and epigenome in the treatment of lung cancer M Sachdeva, N Sachdeva, M Pal, N Gupta, I A Khan, M Majumdar and A Tiwari Cancer Gene Ther 2015 22: 509-517; advance online publication, October 23, 2015; 10.1038/cgt.2015.54 Abstract | Full Text Original Articles Top Conditioned media from human ovarian cancer endothelial progenitor cells induces ovarian cancer cell migration by activating epithelial-to-mesenchymal transition L Teng, S Peng, H Guo, H Liang, Z Xu, Y Su and L Gao Cancer Gene Ther 2015 22: 518-523; advance online publication, October 23, 2015; 10.1038/cgt.2015.45 Abstract | Full Text Integrated analysis of gene expression and genomic aberration data in osteosarcoma (OS) Y Xiong, S Wu, Q Du, A Wang and Z Wang Cancer Gene Ther 2015 22: 524-529; advance online publication, October 2, 2015; 10.1038/cgt.2015.48 Abstract | Full Text Degradation of miR-21 induces apoptosis and inhibits cell proliferation in human hepatocellular carcinoma Z Najafi, M Sharifi and G Javadi Cancer Gene Ther 2015 22: 530-535; advance online publication, October 2, 2015; 10.1038/cgt.2015.51 Abstract | Full Text Upregulation of mitogen-inducible gene 6 triggers antitumor effect and attenuates progesterone resistance in endometrial carcinoma cells W Xu, S Zhu, Y Zhou, Y Jin, H Dai and X Wang Cancer Gene Ther 2015 22: 536-541; advance online publication, October 9, 2015; 10.1038/cgt.2015.52 Abstract | Full Text Efficient expression of bioactive murine IL12 as a self-processing P2A polypeptide driven by inflammation-regulated promoters in tumor cell lines C Lorenzo, G Pérez-Chacón, G Garaulet, Z Mallorquín, J M Zapata and A Rodríguez Cancer Gene Ther 2015 22: 542-551; advance online publication, October 9, 2015; 10.1038/cgt.2015.53 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.